Back
Sonoma Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
24
SNOA
Sonoma Pharmaceuticals
Last Price:
0.15
Seasonality Move:
2.19%
Sell
20
NBY
NovaBay Pharmaceuticals
Last Price:
0.09
Seasonality Move:
-7.96%
Sell
24
Sonoma Pharmaceuticals (SNOA)
is a Sell
Is Sonoma Pharmaceuticals a Buy, Sell or Hold?
- The current Sonoma Pharmaceuticals [SNOA] share price is $0.15. The Score for SNOA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- SNOA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.09. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SNOA Stock Price Chart
What is Sonoma Pharmaceuticals's stock price today?
-
The Sonoma Pharmaceuticals share price today is $0.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNOA is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.09
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNOA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 43.88 | Sell |
| Chaikin Money Flow: | -67737 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.15 - 0.17) | Sell |
| Bollinger Bands (100): | (0.14 - 0.18) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 43.3 | Sell |
| Chaikin Money Flow: | 1873744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.1) | Sell |
| Bollinger Bands (100): | (0.1 - 0.2) | Sell |
SNOA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.15 | Sell |
| 20-day SMA: | 0.16 | Sell |
| 50-day SMA: | 0.15 | Sell |
| 200-day SMA: | 0.4 | Sell |
| 8-day EMA: | 0.15 | Sell |
| 20-day EMA: | 0.16 | Sell |
| 50-day EMA: | 0.16 | Sell |
| 200-day EMA: | 0.43 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.09 | Sell |
| 20-day SMA: | 0.08 | Buy |
| 50-day SMA: | 0.11 | Sell |
| 200-day SMA: | 0.31 | Sell |
| 8-day EMA: | 0.09 | Sell |
| 20-day EMA: | 0.09 | Sell |
| 50-day EMA: | 0.11 | Sell |
| 200-day EMA: | 0.54 | Sell |
Sonoma Pharmaceuticals Earnings Growth & SNOA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Sonoma Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||